Dysentery vaccine

Drug Profile

Dysentery vaccine

Alternative Names: Diarrhoea vaccine

Latest Information Update: 24 Nov 2015

Price : $50

At a glance

  • Originator Shanxi Kangbao Biological Product
  • Developer Academy of Military Medical Sciences; Shanxi Kangbao Biological Product
  • Class Antidiarrhoeals; Vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • On Fast track

    Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.

  • New Molecular Entity No

Highest Development Phases

  • Phase III Dysentery

Most Recent Events

  • 24 Nov 2015 Phase-III development for Dysentery is ongoing in China
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top